A simple sarcopenia screening test predicts future adverse events in patients with heart failure
Yoshiro Onoue(Kumamoto University), Seiji Hokimoto(Omuta hospital), Kenji Sakamoto(Kumamoto University), Satoru Yamamura(Kumamoto University), Shinsuke Hanatani(Kumamoto University), Tomoko Tanaka(Kumamoto University), Eiichiro Yamamoto(Kumamoto University), Sunao Kojima(Kumamoto University), Koichi Kaikita(Kumamoto University), Megumi Yamamuro(IRYO Sosei University), Satoshi Araki(Kumamoto University), Kenichi Tsujita(British Heart Foundation), Yasuhiro Izumiya(Kumamoto University), Yuichi Kimura(Kumamoto University)
Cited by 87
Related Papers
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2015|449
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
|New England Journal of Medicine|2024|356
Guidelines for Gastroenterological Endoscopy in Patients Undergoing Antithrombotic Treatment: 2017 Appendix on Anticoagulants Including Direct Oral Anticoagulants
|Digestive Endoscopy|2018|261
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)
|Circulation|2018|242
Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy
|European Heart Journal|2019|229